Physician profile

Tommy Yee

Neurology (Psychiatry & Neurology) · Mcallen, TX

NPI 1548244668

$2,128.66

in general payments reported to CMS, 2019-2025

23 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kyowa Kirin, INC. $265.16 2019-2020
Acadia Pharmaceuticals INC $256.23 2019-2020
Genentech USA, INC. $206.69 2019-2020
Supernus Pharmaceuticals, INC. $156.04 2019
Mdd US Operations, LLC $139.97 2019-2020
Ucb, INC. $136.40 2019-2020
Amgen INC. $120.13 2019
Genzyme Corporation $118.11 2019-2020
Abbvie INC. $114.84 2019-2020
Acorda Therapeutics, INC $109.59 2020
Teva Pharmaceuticals USA, INC. $86.54 2020
Adamas Pharmaceuticals, INC. $72.02 2019-2020
Lilly USA, LLC $70.25 2019
Sk Life Science, INC. $53.38 2020
Upsher-Smith Laboratories LLC $38.57 2020
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $37.23 2020
Alexion Pharmaceuticals, INC. $26.38 2019
Eisai INC. $25.00 2020
Ge Healthcare $22.20 2019
Medtronic USA, INC. $21.44 2019
Novartis Pharmaceuticals Corporation $20.19 2020
Catalyst Pharmaceuticals, INC. $18.09 2020
Amneal Pharmaceuticals LLC $14.21 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tommy Yee

$2,128.66

in general payments reported 2019-2025

Years
2019-2020
Top company
Kyowa Kirin, INC.

https://glasscript.com/doctor/341921/tommy-yee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.